Lung disease: Resetting the redox balance in lung fibrosis

Nature Reviews Drug Discovery

Volumn 13, Issue 6, 2014, Pages 415-

  Bray, Natasha ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GKT 137831; OXIDOREDUCTASE INHIBITOR; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

DRUG TARGETING; ENZYME INHIBITION; FIBROSING ALVEOLITIS; LUNG FIBROSIS; MYOFIBROBLAST; NONHUMAN; NOTE; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; SENESCENCE; AGING; ANIMAL; FEMALE; HUMAN; METABOLISM; PATHOLOGY;

AGING; ANIMALS; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; NADPH OXIDASE; NF-E2-RELATED FACTOR 2;

EID: 84901931340     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4344     Document Type: Note

References (1)

1. ORIGINAL RESEARCH PAPER Hecker, L. et al. Reversal of persistent fibrosis in aging by targeting Nox4.Nrf2 redox imbalance. Sci. Trans. Med. 6, 231ra47 (2014)